Skip to main content
M. Houman Fekrazad, MD, Oncology, Valencia, CA

M. HoumanHoumanFekrazadMD

Oncology Valencia, CA

Associate Professor, Hematology-Medical Oncology City of Hope National Center

Dr. Fekrazad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fekrazad's full profile

Already have an account?

  • Office

    28860 Plaza de Oro
    Valencia, CA 91354
    Phone+1 708-997-4666
    Fax+1 661-951-0686

Education & Training

  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009
  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Internal Medicine, 2004 - 2006
  • Physicians Medical Center Carraway
    Physicians Medical Center CarrawayResidency, Internal Medicine, 2003 - 2004
  • Shiraz University of Medical Sciences
    Shiraz University of Medical SciencesClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2025
  • NM State Medical License
    NM State Medical License 2005 - 2015
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
  • People's Caring Awards by Patients Living Through Cancer PTLC, 2012
  • "Fellow of The Year" (Department of Internal Medicine) University of New Mexico, 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers  
    Bauman J, Shaheen M, Verschraegen CF, Belinsky SA, Houman Fekrazad M, Lee FC, Rabinowitz I, Ravindranathan M, Jones DV Jr, Transl Oncol, 1/17/2014
  • Spontaneous Regression of High Grade Primary Gastric Lymphoma in an Untreated Viral Hepatitis Infection  
    Rojas-Hernandez CM, Coleman JF, Czuchlewski DR, Fekrazad MH, Leuk Lymphoma, 1/17/2014
  • Hypertrophic Lichen Planus Mimicking Squamous Cell Carcinoma of Skin  
    Murad W, Fekrazad MH, J Am Osteopath Assoc, 1/11/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Phase II Trial of Sorafenib and Capecitabine for Hepatocellular Carcinoma in Cirrhotic Patients
    Fekrazad MH, ASCO Annual Meeting, 1/1/2013
  • Phase II Trial of Combination Oxaliplatin, Capecitabine, Celecoxib With Concurrent Radiation For Patients With Newly Diagnosed Resectable Rectal Cancer
    Fekrazad MH, ASCO GI, 1/1/2013
  • Phase II Trial of Temsirolimus and Erlotinib in Patients With Recurrent/Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma
    Fekrazad MH, ASCO Annual Meeting, 1/1/2012
  • Join now to see all

Lectures

  • Transdermal Delivery of TKI's/Chemotherapy via Nanoparticle 
    1/1/2014
  • Hematology-Oncology Emergencies 
    University of New Mexico - 1/1/2011
  • EBV-Associated Follicular Dendritic Cell Tumor of The Spleen 
    1/1/2007

Other

  • Diagnosis, Prevention and Treatment of Rejection in Cardiac Transplantation, Thesis 
    Fekrazad MH, Sanjarian A
    Shiraz University School of Medicine - 1/1/1993
  • Effects of IV Metronidazole in Treatment of 31 Patients with Pseudomembraneous 
    Fekrazad MH, Shiraz University School of Medicine Press
    1/1/1993
  • Effects of Hydralazine on 23 Preeclamptic Patients 
    Fekrazad MH, Shiraz University School of Medicine Press
    1/1/1992